Back to Authors

Kwon, Minkyung

https://orcid.org/0000-0003-2437-7606

A5072173529 | I1330342723

Mayo Clinic

Division of Pulmonary, Allergy, and Sleep Medicine

Citations 8

Interstitial Lung Disease in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Patients

JCR: Journal of Clinical Rheumatology | April 6, 2020 | Volume: 27 | Issue: 8 | Pages: 324-330

10.1097/rhu.0000000000001357 | PMID 32251058

Background/Objective Antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV) may involve the kidney, respiratory tract, skin, or central and peripheral nervous system. Reports of interstitial lung disease (ILD) in AAV (AAV-ILD) have been increasing. Methods We reviewed the medical records of all patients with AAV-ILD between January 1, 2007, and December 31, 2017, and compared their pulmonary involvement to patients with idiopathic pulmonary fibrosis (IPF). Results We identified 24 patients with AAV-ILD: 14 with microscopic polyangiitis, 8 with granulomatosis with polyangiitis, and 2 with eosinophilic granulomatosis with polyangiitis. Perinuclear or myeloperoxidase ANCA was present in 16 cases (66.7%), whereas cytoplasmic or proteinase 3 ANCA was positive in 8 (33.3%). Usual interstitial pneumonia (UIP) was seen in 11 (45.8%), probable UIP in 1 (4.2%), indeterminate UIP in 2 (8.3%), and an alternate diagnosis in 10 (41.7%), and was further characterized as chronic hypersensitivity pneumonitis-like pattern seen in 6 (25%), nonspecific interstitial pneumonia-like pattern in 3 (12.5%), and cryptogenic organizing pneumonia-like pattern in 1 (4.2%). Forced vital capacity and diffusing capacity declined over time in patients with AAV-ILD. When compared with the IPF cohort, patients with AAV-ILD had intermediate survival and speed of lung function decline (3-year survival in AAV-ILD group was 94% vs 69% in IPF). Conclusions Antineutrophil cytoplasmic antibody–associated vasculitis ILD is a progressive and potentially fatal condition. Although most cases in the literature are associated with p-ANCA and positive myeloperoxidase, we found that a third of patients had c-ANCA or granulomatosis with polyangiitis. Our cohort adds experience in this rare manifestation of AAV.
Extracorporeal Liver Support for the Treatment of Hyperammonemia After Lung Transplantation

Transplantation | August 5, 2019 | Volume: 104 | Issue: 3 | Pages: e75-e76

10.1097/tp.0000000000002881 | PMID 31385932

1047 Caught on Camera: Interpretation of Polysomnogram

Sleep | April 13, 2019 | Volume: 42 | Issue: Supplement_1 | Pages: A420-A420

10.1093/sleep/zsz069.1044

1016: USEFULNESS OF POINT-OF-CARE ULTRASOUND FOR CHARACTERIZATION OF PRE-LIVER TRANSPLANT PLEURAL EFFUSION

Critical Care Medicine | December 18, 2018 | Volume: 47 | Issue: 1 | Pages: 486-486

10.1097/01.ccm.0000551764.90373.73

642: SUCCESSFULLY TREATED MUCORMYCOSIS WITH INTRAPLEURAL AMPHOTERICIN B AND PNEUMONECTOMY

Critical Care Medicine | December 18, 2018 | Volume: 47 | Issue: 1 | Pages: 301-301

10.1097/01.ccm.0000551394.22198.31

1166: NIVOLUMAB-INDUCED PNEUMONITIS LEADING TO RESPIRATORY FAILURE

Critical Care Medicine | December 18, 2018 | Volume: 47 | Issue: 1 | Pages: 560-560

10.1097/01.ccm.0000551911.05745.17

1105 Ophthalmic Conditions and Sleep Apnea-Hypopnea Syndrome: Uncharted Territory

Sleep | April 27, 2018 | Volume: 41 | Issue: suppl_1 | Pages: A410-A411

10.1093/sleep/zsy063.1104

1106 A Walk on the Beach May Become What the Doctor Recommends

Sleep | April 27, 2018 | Volume: 41 | Issue: suppl_1 | Pages: A411-A411

10.1093/sleep/zsy063.1105